Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

30.87 +1.38 (+4.68%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
99 100 Next >
News headline image
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings ↗
The Senate will meet Wednesday to start the confirmation hearing process for Robert F. Kennedy Jr. 
Via Investor's Business Daily
News headline image
Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Via ACCESS Newswire
News headline image
3 ETFs Shine As Trump's First Week Sparks Record Gains Followed By Tech Slump ↗
The S&P 500 had a strong first week, with ETFs such as SPY, VOO and IVV seeing gains. Were Trump's economic policies a factor? 
Via Benzinga
Topics ETFs Government Stocks
News headline image
Top S&P500 movers in Tuesday's session ↗
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
How Is The Market Feeling About Moderna? ↗
 
Via Benzinga
News headline image
3 Things You Need to Know if You Buy Moderna Today ↗
Via The Motley Fool
News headline image
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Via ACCESS Newswire
News headline image
Moderna Unusual Options Activity For January 22 ↗
 
Via Benzinga
News headline image
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? ↗
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald... 
Via Benzinga
Topics Government
News headline image
ETFs Shine As S&P 500 Hits Record High: Top 5 ETFs With Best Gains From Last Week ↗
Global economy and financial markets saw a lot of activity in Jan. 24 week. S&P 500 reached record high, several ETFs had double-digit gains. 
Via Benzinga
Topics ETFs Economy Stocks
News headline image
10 Worst Performing Large-Caps Last 12 Months ↗
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
News headline image
Netflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio? ↗
12 large-cap stocks saw significant gains last week, including Summit Therapeutics, Rocket Lab, Moderna, and Netflix. Analysts raised price forecasts. 
Via Benzinga
News headline image
Why Is Moderna Stock Trading Higher On Tuesday? ↗
Moderna secures $590 million from HHS for mRNA flu vaccine development. 
Via Benzinga
News headline image
Where Will Moderna Be in 3 Years? ↗
Via The Motley Fool
News headline image
Why Moderna Stock Jumped Over 20% This Week ↗
Are you ready for artificial intelligence (AI)-driven mRNA vaccines? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Beaten-Down Stocks That Haven't Been This Cheap in More Than 3 Years: Are They Bargain Buys? ↗
Via The Motley Fool
News headline image
Trump Sparks Records On Wall Street, AI Stargate Project Lifts Chipmakers; Inflation, Tariff Jitters Arise: This Week In The Market ↗
Wall Street hit new records as Donald Trump began his second term as 47th U.S. president this week. 
Via Benzinga
Topics Artificial Intelligence Economy Government
News headline image
Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week High ↗
The agreement, which spans up to four years, allows 17 participating countries access to Moderna’s vaccine in various formats. 
Via Stocktwits
News headline image
Moderna Secures European Contract For Covid-19 Vaccine ↗
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to enhance healthcare delivery. 
Via Benzinga
News headline image
Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots ↗
Moderna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains. 
Via Investor's Business Daily
News headline image
Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads ↗
As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all communications from the Centers for Disease Control and Prevention to stop. 
Via Benzinga
Topics Government
News headline image
Moderna Shares Are Up Today: What's Going On? ↗
Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines ↗
Ellison, Oracle's chairman, pointed to the use of AI to develop drugs like Moderna's cancer vaccine. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
These 3 Stocks Are Down to Start 2025. What's Going On? ↗
Sonos, Moderna, and Shake Shack are all staring at some near-term headwinds – can they work through them? 
Via The Motley Fool
News headline image
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
After a Reset Year, Is Moderna Stock Poised for a Comeback?
Moderna had a rough 2024 and is starting 2025 with lowered forecasts, but is focused on getting 10 FDA approvals in the next three years. Is now time to buy? 
Via MarketBeat
News headline image
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine ↗
According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus. 
Via Benzinga
News headline image
Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under Trump ↗
In 2023, Moderna initiated a Phase 1/2 study to assess the safety and immunogenicity of its investigational bird flu vaccine, mRNA-1018, in healthy adults aged 18 and older. 
Via Stocktwits
News headline image
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
3M, Netflix And 3 Stocks To Watch Heading Into Tuesday ↗
US stock futures trading higher on Tuesday. Stocks to watch: 3M, D.R. Horton, Moderna, United Airlines, Netflix. 
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.